KRAS and non-small cell lung carcinoma: Moreover, this study mentioned that KRAS mutation occurrence in NSCLC patients in the Chinese population (5.8%) is similar to that of the same demographic of patients in East Asian countries and in the USA population, while this number was shown to be higher in Western countries.